HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BIM-23A761

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Catecholamines: 15682
    - Dopamine: 23033
      - BIM-23A761: 2
  - Biogenic Amines: 992
    - Biogenic Monoamines: 29
      - Dopamine: 23033
        BIM-23A761: 2
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Catecholamines: 15682
        Dopamine: 23033
        BIM-23A761: 2
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Pancreatic Hormones: 113
      - Somatostatin: 8960
        BIM-23A761: 2
    - Hypothalamic Hormones: 68
      - Pituitary Hormone Release Inhibiting Hormones
        Somatostatin: 8960
        BIM-23A761: 2
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Hypothalamic Hormones: 68
        Pituitary Hormone Release Inhibiting Hormones
        Somatostatin: 8960
        BIM-23A761: 2
- Peptides: 82426
  - Neuropeptides: 6772
    - Hypothalamic Hormones: 68
      - Pituitary Hormone Release Inhibiting Hormones
        Somatostatin: 8960
        BIM-23A761: 2
  - Peptide Hormones: 1347
    - Pancreatic Hormones: 113
      - Somatostatin: 8960
        BIM-23A761: 2
    - Hypothalamic Hormones: 68
      - Pituitary Hormone Release Inhibiting Hormones
        Somatostatin: 8960
        BIM-23A761: 2

Experts

1.	Culler, Michael D: 1 article (10/2012)
2.	Gruszka, Anna: 1 article (10/2012)
3.	Melmed, Shlomo: 1 article (10/2012)
4.	Culler, M D: 1 article (07/2005)
5.	Dong, J: 1 article (07/2005)
6.	Dufour, H: 1 article (07/2005)
7.	Enjalbert, A: 1 article (07/2005)
8.	Gunz, G: 1 article (07/2005)
9.	Jaquet, P: 1 article (07/2005)
10.	Kim, S: 1 article (07/2005)

Related Diseases

1.	Adenoma (Adenomas) 07/01/2005 - "This study compared the potency of a somatostatin receptor (sstr)2-sstr5 analog, BIM-23244, of an sstr2-dopamine D2 receptor (sstr2-DAD2) molecule, BIM-23A387 and of new somatostatin-dopamine chimeric molecules with differing, enhanced affinities for sstr2, sstr5 and DAD2, BIM-23A758, BIM-23A760 and BIM-23A761, to suppress GH and prolactin (PRL) from 18 human GH adenomas that are partially responsive to octreotide or lanreotide. "
2.	Pituitary Neoplasms (Pituitary Adenoma) 10/15/2012 - "We tested effects of selective somatostatin receptor 2 (SST2) agonist BIM-23120, SST5 agonist BIM-23206 and chimeric somatostatin-dopamine molecules (SRIF/DA) BIM-23A760 and BIM-23A761 on GH and PRL secretion and gene expression in human GH/PRL-secreting pituitary tumors in vitro. "

Related Drugs and Biologics

1.	Somatostatin (Somatotropin Release-Inhibiting Factor)
2.	Dopamine (Intropin)
3.	TBR-760
4.	Somatostatin Receptors (Somatostatin Receptor)
5.	Octreotide (Sandostatin)
6.	Prolactin
7.	BIM-23A387
8.	BIM-23244
9.	lanreotide (Somatuline)
10.	BIM 23206